Targeting cancer-associated fibroblast by biomimetic nanomissiles to remodel tumor stromal microenvironment for colorectal cancer liver metastasis
Source abstract
Abstract
Cancer-associated fibroblasts (CAFs) play a critical linchpin behind the colorectal cancer liver metastasis (CRLM) and immunological escape by the aberrant deposition of extracellular matrix (ECM). Herein, we crafted an intricately designed biomimetic nanoparticle architecture (denoted as UDCA-Cu@DMSN-M) that leveraged dendritic mesoporous silica nanoparticle (DMSN) as a versatile scaffold to enable the encapsulation of copper ions (Cu 2+ ) and ursodeoxycholic acid (UDCA) in their intricate cavities, and camouflaged with CAF membrane (CAFM) to augment CAF-site targeting. To encapsulate, the judicious integration of a myriad of interdependent attributes into a single material has the potential to trigger a cascading “domino effect” that encompasses CAFs reprogramming, ECM process reversal, epithelial-mesenchymal transition (EMT) inhibition, and antitumor immunity reinvigorating, thereby paving the way for innovative and comprehensive cancer treatment paradigms. A biomimetic CAF membrane-camouflaged nanomedicine has been developed for colorectal cancer liver metastasis. This platform co-delivers copper ions and ursodeoxycholic acid to reprogram cancer-associated fibroblasts and boost antitumor immunity, achieving synergistic treatment cascade. • Construct CAF membrane-camouflaged UDCA-Cu@DMSN-M for precise CAF targeting. • Synergize cuproptosis and TGF-β degradation to reprogram CAFs & reverse ECM deposition. • Activate antitumor immunity, potently inhibit CRLM with good biocompatibility.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · Nanoplatforms for cancer theranostics · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis10.1136/gutjnl-2023-330243 ↗
2. Colorectal liver metastasis: molecular mechanism and interventional therapy10.1038/s41392-022-00922-2 ↗
3. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level10.1158/2159-8290.CD-21-0316 ↗
4. Current status of nerve infiltration by skip metastases in colorectal cancer
5. Immunomodulatory molecules in colorectal cancer liver metastasis10.1016/j.canlet.2024.217113 ↗
6. Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis10.1038/s41467-025-56299-7 ↗
7. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets10.1126/scitranslmed.adg3840 ↗
8. Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy10.1002/bmm2.70019 ↗
9. Intestinal stem cells (iscs): Iscs-derived organoids for disease modeling and therapy10.22203/eCM.v050a05 ↗
10. The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors10.1016/j.drup.2025.101273 ↗
11. A collagenase nanogel backpack improves car-t cell therapy outcomes in pancreatic cancer10.1038/s41565-025-01924-1 ↗
12. In vivo fap-car macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier10.1016/j.jconrel.2025.113888 ↗
13. Cancer-associated fibroblast-derived extracellular vesicles loaded with glut1 inhibitor synergize anti-pd-l1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment10.1016/j.jconrel.2025.113998 ↗
14. Molecular pathways: targeting the microenvironment of liver metastases10.1158/1078-0432.CCR-15-1636 ↗
15. Targeting the egfr signalling pathway in metastatic colorectal cancer10.1016/S2468-1253(23)00479-X ↗
16. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer10.1038/s41392-024-01859-4 ↗
17. A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy10.1038/s41565-022-01098-0 ↗
18. Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy10.7150/thno.108875 ↗
19. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy10.1038/s41467-024-54469-7 ↗
20. Ultrasound-activated probiotics vesicles coating for titanium implant infections through bacterial cuproptosis-like death and immunoregulation
21. Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system10.1016/j.biomaterials.2025.123201 ↗
22. Ursodeoxycholic acid reduces antitumor immunosuppression by inducing chip-mediated tgf-β degradation10.1038/s41467-022-31141-6 ↗
23. Tgf-β and ras jointly unmask primed enhancers to drive metastasis10.1016/j.cell.2024.08.014 ↗
24. Tnc-targeted car-macrophage therapy alleviates liver fibrosis in mice
25. Unique advantages of dendrimers-structured mesoporous silica nanoparticles over traditional hollow ones in delivering bcl2-functional converting peptide for multidrug resistant cancer treatment10.1002/adhm.202400888 ↗
26. Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer
27. Spatial isolation of single copper(i) sites for cascade enzyme‐like catalysis and simultaneous ferroptosis/cuproptosis boosted immunotherapy10.1002/EXP.20240275 ↗
28. Multi-hierarchical fe single atom nanozymes with axially-coordinated o-fe-n4 active centers reshape macrophage epigenetics against immunosuppression10.1002/adfm.202408141 ↗
29. Supramolecular artificial nano-autacs enable tumor-specific metabolism protein degradation for synergistic immunotherapy10.1126/sciadv.adn8079 ↗
30. Alternative splicing in emt and tgf-β signaling during cancer progression10.1016/j.semcancer.2024.04.001 ↗
31. Hif1α counteracts tgfβ1-driven tsp1 expression in endothelial cells to stimulate angiogenesis in the hypoxic tumor microenvironment10.1158/0008-5472.CAN-24-2324 ↗
32. Bile acid receptors as targets for drug development10.1038/nrgastro.2013.151 ↗